Innovations In Clinical Neuroscience

MAR-APR 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 44 of 45

[ V O L U M E 1 4 , N U M B E R 3 – 4 , M A R C H – A P R I L 2 0 1 7 ] Innovations in CLINICAL NEUROSCIENCE 45 Submission requirements for Innovations in Clinical Neuroscience (Online ISSN 2158-8341, Print ISSN 2158-8333) are in accordance with the International Committee of Medical Journal Editors (ICMJE). See Uniform Requirements for Manuscripts Submitted to Biomedical Journals. EDITORIAL PURPOSE Innovations in Clinical Neuroscience is a peer- reviewed electronic-only journal ( designed to provide healthcare clinicians and researchers with up-to-date, evidence-based information in a straightforward "how-to" fashion on new or emerging treatment options, drug development trends, theoretical concepts, drug trial methodology, and practice management issues in the field of neuroscience, including psychiatry, neurology, pain, and Alzheimer's, to improve patient outcomes. SCOPE OF MANUSCRIPTS Manuscripts that meet our editorial purpose include but are not limited to: (1) reports of preclinical and clinical research studies that expand existing knowledge in the field of neuroscience; (2) case reports, case series, and case studies that stimulate research and the exchange of information beyond what is currently found in the literature in the field of neuroscience; (3) in-depth reviews that synthesize new or emerging information on treatment options, drug development, drug trial methodology, practice management, reimbursement, education, ethics, and legal issues in the field of neuroscience; (4) reports on contemporary issues in neuroscience that may affect drug or device development, delivery of services, reimbursement, and clinical practice of psychiatry, neurology, or related fields; and (5) commentaries that offer unique, substantiated discussions on theorectical concepts, current or emerging trends in clinical practice (including treatment and diagnosis issues), trial methodology, drug development, regulatory issues, or other topics related to neuroscience that affect patient outcome. Original Research. Reports of investigations that address questions about clinical care or clinical trial methodology or expand existing knowledge. References and abstract are required. Illustrative material is recommended. Recommended length: up to 6000 words, not including references. Review Articles. Comprehensive articles that synthesize and summarize the latest research to facilitate the clinician's approach to diagnosis and treatment and articles highlighting emerging diagnostic and therapeutic modalities. May also include in-depth reviews of clinical practice, pracice management, drug development, trial methodology, reimbursement and educational, ethical, or legal issues. References (at least 25 current references are recommended) and abstract required. Illustrative material is preferred. Recommended length: up to 6000 words, not including references. Case Series, Studies, or Reports. Short presentations of actual cases that stimulate research and the exchange of information beyond what is currently found in the literature and illustrate the signs and symptoms, diagnosis, and treatment of a disorder. Case presentations should provide unique or new information that is not well-covered in the current literature. References (at least 15 current references are recommended) and abstract required. Illustrative material is preferred. Recommended length 1000 to 3000 words, not including references. Brief Reports. Short reports of original studies, trial methodology, or case series. Must include abstract. Recommended length: 1000 to 1500 words (not including references). Commentaries. Essays that address important topics in neuroscience and generally are not linked to a specific article. Commentaries should offer unique perspectives that are well focused, scholarly, and clearly presented. Include approximately 20 references. Recommended length: 1500 to 2000 words. Letters to the Editor. Opinions on cases or articles published in Innovations in Clinical Neuroscience, opinions on other current topics, or short reports of clinical interest. Must be concise and to the point. Text should not exceed 600 words (not including references), with no more than 10 references. Letters regarding a specific article published in Innovations in Clinical Neuroscience should be received within four months of the article's publication release and may be sent to the original author for reply. Submission of a letter does not guarantee publication or response. Notify editor if letter is not intended for publication should be The editor reserves the right to edit the material for style, clarity, and size. MANUSCRIPT SUBMISSION Submissions for consideration may be submitted online via Editorial Manager available at Emailed submissions no longer accepted. Corresponding Author. Each manuscript submission should have a designated corresponding author. The corresponding author will be the editor's single point of contact and will be responsible for communicating any information from the editor regarding the submitted manuscript to the coauthors. Cover Letter. Manuscripts should be submitted with a cover letter indicating the article type. The cover letter should give details on any previous or duplicate publication of any of the content and should state that the paper is not under consideration for publication elsewhere. In the cover letter, authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript. For Letters to the Editor, please indicate whether the letter is intended for publication. Conflict of Interest Disclosures. All authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript in the cover letter of the submitted manuscript. Author and Copyright Forms. Upon submission, corresponding author will receive an acknowledgement email with author and copyright forms attached. It is the responsibility of the corresponding author to distribute the author and copyright forms to all of the coauthors. All authors for each submission are required to complete, sign, and return these forms prior to publication. The corresponding author may not sign on behalf of any coauthor.If the manuscript is accepted and published in Innovations in Clinical Neuroscience, authors must transfer copyright to Matrix Medical Communications. Registration of Clinical Trials. As recommended by the ICMJE, Innovations in Clinical Neuroscience requires as a condition of consideration for publication registration of all clinical trials in a public trials registry that requires the minimum registration data set as determined by the ICMJE, which can be accessed via Please include the trial registry name, registration number, and the url for the registry in the abstract. Inclusion of Previously Published Materials. Any material submitted to Innovations in Clinical Neuroscience that is reproduced from previously published copyrighted material must be accompanied by a letter of permission from the copyright holder UPON SUBMISSION. All such material should include a full credit line (e.g., in the figure or table legend) acknowledging the original source. The author is responsible for obtaining the permission and is responsible for any associated fees. MANUSCRIPT PREPARATION Title Page. The title page should contain the following elements: title, author names and institutional affiliations, sources of financial support, name of corresponding author with his or her complete contact information (mailing address, telephone and fax numbers, e-mail address), and word count (text only). Spacing and Pagination. The manuscript should be typed using double spacing throughout. Do not use a running head. Pages should be numbered beginning with the title page. Manuscripts should NOT contain any automatic formatting, except for the page number at the top right corner of each page. Abstract. Include a structured abstract with all articles, except letters to the editors. Original research abstracts should be organized using the following categories: Objective, Design, Setting, Participants, Measurements, Results, Conclusion. Abstracts of clinical trials must include trial registry information (registry name, registration number, and url for the registry). Review article, case report, and brief report, abstracts should be organized using the following categories: Objective, Method, Results, Conclusion. Abstracts of commentaries should include the following categories: Objective, Main Points of Discussion, Conclusion. Keywords. Include all relevant keywords following the abstract. Author Guidelines

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - MAR-APR 2017